Tecnis, a multifocal lens for cataract patients developed by Abbott Laboratories, has been granted approval by U.S. Food and Drug Administration.

Piramal Life Sciences Limited, a leading life sciences company from India, has reported clinical trial data on psoriasis drug Tinefcon suggesting that the experimental phytopharmaceutical product is safe.

GE Healthcare has commenced production of high-speed dual slice computed tomography (CT) imaging system in Bangalore.

A personalized immunotherapeutic AGS-003 to treat metastatic kidney cancer (renal cell carcinoma) by Argos Therapeutics has shown that the experimental drug could be more effective than interferon-alfa.

IMGN901, an investigational drug to treat Merkel cell carcinoma (MCC) developed by ImmunoGen, Inc., has been granted Orphan Drug designation in US.